Novo Nordisk Dividend
Dividend criteria checks 3/6
Novo Nordisk is a dividend paying company with a current yield of 1.05% that is well covered by earnings.
Key information
1.1%
Dividend yield
50%
Payout ratio
Industry average yield | 2.4% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Earnings per share | US$18.76 |
Dividend yield forecast in 3Y | 1.8% |
Recent dividend updates
Recent updates
Novo Nordisk: The Moat Won't Last Forever
Apr 09Shaping The Future Of Obesity Treatment: GLP-1 Agonists At The Forefront
Mar 18Novo Nordisk: My 'Hold' Thesis For 2024 - The Premium Must Be Justified
Mar 07Novo Nordisk, A Very Healthy Pharma Stalwart
Feb 28Novo Nordisk: SOTP After Impressive FY23 And Weight Loss Going Mainstream, Maintain Buy
Feb 23Novo Nordisk: Irrational Exuberance Isn't Worth The Risk
Feb 16Novo Nordisk: Outlook For Weight Loss Drugs In 2024
Jan 22Taking Novo Nordisk To The Next Level
Jan 15Profiting From Obesity Drugs HRTS, Novo Nordisk And Eli Lilly
Jan 02Novo Nordisk: Latest Insights Confirm Exceptionally Bullish Opportunity
Dec 12Novo Nordisk: Eli Lilly's Zepbound Approval Is Not A Threat To Valuation
Nov 24Novo Nordisk: Growing To Potentially Become The First Trillion-Dollar European Champion
Oct 24Novo Nordisk: Catching The Falling Knife Now Could Really Hurt
Sep 22Novo Nordisk: Strong Fundamentals Meet Technical Uptrends
Aug 30Novo Nordisk: Denmark's Coca-Cola
Jul 25The Case For Novo Nordisk: Growth, Dividends, And A New Treatment Frontier
Jul 11Novo Nordisk Is A Hold Despite Explosive Growth In Diabetes And Obesity Care
Jun 23Novo Nordisk: Dominating In Diabetes And Obesity
Jun 05Novo Nordisk: Flourishing Financials And Emerging Opportunities In Diabetes And Obesity
May 23Novo Nordisk: Attractive Market But Likely No Margin Of Safety
Feb 15Novo Nordisk to sell Wegovy in bigger European markets -- Bloomberg
Feb 07Novo Nordisk FY 2022 Earnings Preview
Jan 31Novo Nordisk says FDA updated label for oral diabetes therapy Rybelsus
Jan 13Stability and Growth of Payments
Fetching dividends data
Stable Dividend: NVO's dividend payments have been volatile in the past 10 years.
Growing Dividend: NVO's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
Novo Nordisk Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (NVO) | 1.1% |
Market Bottom 25% (US) | 1.5% |
Market Top 25% (US) | 4.7% |
Industry Average (Pharmaceuticals) | 2.4% |
Analyst forecast in 3 Years (NVO) | 1.8% |
Notable Dividend: NVO's dividend (1.05%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.54%).
High Dividend: NVO's dividend (1.05%) is low compared to the top 25% of dividend payers in the US market (4.73%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonable payout ratio (50.4%), NVO's dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonable cash payout ratio (59.9%), NVO's dividend payments are covered by cash flows.